Media
Press and media
EASL collaborates with a range of trusted media partners to amplify the reach of liver science and share the latest developments in hepatology with a wider audience. Through these partnerships, we promote EASL events, publications and initiatives, while supporting accurate, high-quality coverage of advances in liver research and care. If you are a media outlet interested in covering EASL activities or becoming a media partner, we invite you to get in touch with us.
Press Releases
- EASL News, Press Release
EASL-ESCMID Position Paper: Patients with advanced liver disease and transplant recipients require specific care during COVID-19
The European Association for the Study of the Liver (EASL) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) have issued a Position…
- Press Release
Global hepatology societies call for better HCV testing and access to treatment
Four societies focused on liver disease research and treatment announced a global call-to-action initiative to simplify hepatitis C testing and treatment. BOSTON, 8 November 2019….
- Press Release
Obesity epidemic results in Non-Alcoholic Fatty Liver Disease (NAFLD) becoming the most common cause of liver disease in Europe.
World´s leading experts gather in Seville to discuss the fastest growing health epidemic in Europe now affecting 1 in 4 people. 26 September 2019 –…
- EASL News, Press Release
LITMUS – Progress towards diagnosing and better treating liver disease
A pioneering European research project, designed to develop new diagnostic tests to assess patients with Non-Alcoholic Fatty Liver Disease (NAFLD) has expanded giving access to…
- EASL News, Press Release
EASL Governing Board appoints Ben Hainsworth as incoming Managing Director
Starting September 2019 Hainsworth will serve as the interface between the EASL Governing Board and the organisation`s Geneva and Brussels operations, ensuring high quality and…
- EASL News, Press Release
Journal of Hepatology achieves best ranked publication on liver disease
GENEVA, Switzerland Last week, ClarivateTM Analytics released the 2019 update of its Journal Citation Reports©, including the much anticipated 2018 impact factor. EASL’s flagship monthly…
- Press Release
Genetic analysis has potential to transform diagnosis and treatment of adults with liver disease of unknown cause
Whole-exome sequencing successfully diagnosed genetic cause of liver disease in one in four adults and could play a key role in timely diagnosis and treatment…
- Press Release
Treatment with high doses of albumin improves cardiac function and reduces systemic inflammation in patients with decompensated cirrhosis
According to a study conducted by the EF-Clif published in Gastroenterology This study has shown for the first time that the administration of albumin at…
- Press Release
The WHO guidelines for chronic hepatitis B fail to detect half of the patients in need of treatment in Ethiopia
A revision is proposed for current WHO guidelines for chronic hepatitis B (CHB) as they fail to detect half of the patients in need of…
- Press Release
Antiviral therapy improves survival rates for kidney transplant recipients with hepatitis B or C
In a new study in the Journal of Hepatology, researchers report favorable 10-year survival rates for patients with HBV and/or HCV treated with antiviral agents…